TherapeuticsMD, Inc. financial data

Symbol
TXMD on Nasdaq
Industry
Pharmaceutical Preparations
Location
951 Yamato Road, Suite 220, Boca Raton, Florida
State of incorporation
Nevada
Fiscal year end
December 31
Former names
AMHN, Inc. (to 9/14/2011), CROFF ENTERPRISES INC (to 9/4/2009), CROFF OIL CO (to 4/1/1997)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 134 % +166%
Quick Ratio 3.44 % -67.9%
Debt-to-equity 71.8 %
Return On Equity -21.4 % -106%
Return On Assets -19.9 % -122%
Operating Margin 59.9 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.5M shares +9.05%
Common Stock, Shares, Outstanding 11.5M shares +9.05%
Entity Public Float 34.4M USD -60.6%
Common Stock, Value, Issued 11K USD 0%
Weighted Average Number of Shares Outstanding, Basic 11.5M shares +12.8%
Weighted Average Number of Shares Outstanding, Diluted 11.5M shares +12.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 69.4M USD +246%
Research and Development Expense 5.51M USD -31.6%
Selling and Marketing Expense 83.7M USD -36.2%
General and Administrative Expense 56.7M USD -29.8%
Operating Income (Loss) -2.44M USD +1.29%
Nonoperating Income (Expense) 1.39M USD +2297%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.05M USD +56.5%
Income Tax Expense (Benefit) -260K USD
Net Income (Loss) Attributable to Parent -6.09M USD -114%
Earnings Per Share, Basic -0.09 USD/shares +62.5%
Earnings Per Share, Diluted -0.09 USD/shares +62.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 32.2M USD -14%
Inventory, Net 6.7M USD -8.98%
Assets, Current 11.8M USD -39.7%
Property, Plant and Equipment, Net 19K USD -96.6%
Operating Lease, Right-of-Use Asset 6.5M USD -10.1%
Intangible Assets, Net (Excluding Goodwill) 4.52M USD -33.1%
Other Assets, Noncurrent 58K USD -77.2%
Assets 40.1M USD -25.3%
Accounts Payable, Current 143K USD -90.5%
Employee-related Liabilities, Current 526K USD -81.5%
Liabilities, Current 5.82M USD -59.5%
Operating Lease, Liability, Noncurrent 6.53M USD -11.4%
Other Liabilities, Noncurrent 637K USD -46.4%
Liabilities 12.5M USD -44.6%
Retained Earnings (Accumulated Deficit) -951M USD -0.64%
Stockholders' Equity Attributable to Parent 27.7M USD -11.3%
Liabilities and Equity 40.1M USD -25.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.7M USD +51.3%
Net Cash Provided by (Used in) Financing Activities -5M USD -105%
Net Cash Provided by (Used in) Investing Activities -212K USD +51.6%
Common Stock, Shares Authorized 32M shares 0%
Common Stock, Shares, Issued 11.5M shares +9.05%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.23M USD -61.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.36M USD -40.1%
Deferred Tax Assets, Valuation Allowance 200M USD -23.4%
Deferred Tax Assets, Gross 200M USD -23.4%
Operating Lease, Liability 8.01M USD -8.61%
Depreciation 100K USD -83.3%
Payments to Acquire Property, Plant, and Equipment 42K USD -33.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -10.3M USD -109%
Lessee, Operating Lease, Liability, to be Paid 10.4M USD -12.2%
Property, Plant and Equipment, Gross 2.52M USD -0.04%
Operating Lease, Liability, Current 1.59M USD +9.74%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.51M USD +2.44%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.48M USD +2.36%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.42M USD -22.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.55M USD +2.51%
Deferred Tax Assets, Operating Loss Carryforwards 158M USD -10.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.59M USD +2.52%
Additional Paid in Capital 979M USD
Depreciation, Depletion and Amortization 180K USD +40.6%
Share-based Payment Arrangement, Expense 1.3M USD -88.8%
Interest Expense 300K USD +50%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%